MULTIPLE MYELOMA OR PLASMACYTOMA

Clinical trials for MULTIPLE MYELOMA OR PLASMACYTOMA explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYELOMA OR PLASMACYTOMA trials appear

Sign up with your email to follow new studies for MULTIPLE MYELOMA OR PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New vaccine aims to stop myeloma from coming back

Disease control Recruiting now

This early-stage trial tests a personalized vaccine made from a patient's own immune cells (dendritic cells) to keep multiple myeloma or plasmacytoma in remission. The study includes 10 patients who have already achieved very good partial or complete remission after other treatme…

Matched conditions: MULTIPLE MYELOMA OR PLASMACYTOMA

Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control

Last updated Jun 11, 2026 12:09 UTC

MULTIPLE MYELOMA OR PLASMACYTOMA

Get alerted when new MULTIPLE MYELOMA OR PLASMACYTOMA trials appear

New vaccine aims to stop myeloma from coming back